Sodium-Hydrogen Exchanger 3 Inhibitors [MoA] - N0000194057

Pharmacologic Code	N0000194057
Pharmacologic Name	Sodium-Hydrogen Exchanger 3 Inhibitors
Pharmacologic Uses	sodium/hydrogen exchanger 3 (NHE3) inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Sodium-Hydrogen Exchanger 3 Inhibitors [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	73154-110	Xphozah 10 Mg	Non-Proprietary Name: Tenapanor	Tablet, Film Coated	Oral	Ardelyx, Inc.	ACTIVE
	73154-120	Xphozah 20 Mg	Non-Proprietary Name: Tenapanor	Tablet, Film Coated	Oral	Ardelyx, Inc.	ACTIVE
	73154-130	Xphozah 30 Mg	Non-Proprietary Name: Tenapanor	Tablet, Film Coated	Oral	Ardelyx, Inc.	ACTIVE